Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion

F. Villani, M. Galimberti, G. Mazzola, I. Stifani, M. Santinami, M. Rizzi, R. Manzi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims: We studied cardiac and pulmunary function in 22 patients affected by in transit metastases from cutaneous melanoma and metastases from soft tissue sarcoma of the limbs and treated with isolation perfusion in extracorporeal circulation with rTNF alpha at doses ranging from 0.5 to 4 mg/m2 in mild hyperthermia. Patients and methods: All patients experienced a septic-like shock syndrome of variable severity: this feature lasted from 24 to 72 h and was controlled by the infusion of dopamine. Seventeen patients suffered from respiratory insufficiency, which required assisted ventilation (7 cases mechanical ventilation for 1 day, 8 cases for 2 days, and 2 cases synchronized intermittent mandatory ventilation). Results: Spirometric parameters recorded 7-15 days after treatment did not change from baseline values. In contrast, lung transfer factor for carbon monoxide significantly declined in a dose dependent fashion. Conclusions: Our data confirm that rTNF alpha administered by isolation perfusion technique induces systemic cardiovascular and pulmonary side effects. Further studies are required to better define time course and reversibility of impaired pulmonary function.

Original languageEnglish
Pages (from-to)197-200
Number of pages4
JournalTumori
Volume81
Issue number3
Publication statusPublished - 1995

Fingerprint

Tumor Necrosis Factor-alpha
Perfusion
Lung
Ventilation
Neoplasm Metastasis
Transfer Factor
Extracorporeal Circulation
Carbon Monoxide
Septic Shock
Artificial Respiration
Respiratory Insufficiency
Sarcoma
Melanoma
Dopamine
Fever
Extremities
Skin
Therapeutics

Keywords

  • cardiotoxicity
  • pneumotoxicity
  • tumor necrosis factor

ASJC Scopus subject areas

  • Cancer Research

Cite this

Villani, F., Galimberti, M., Mazzola, G., Stifani, I., Santinami, M., Rizzi, M., & Manzi, R. (1995). Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion. Tumori, 81(3), 197-200.

Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion. / Villani, F.; Galimberti, M.; Mazzola, G.; Stifani, I.; Santinami, M.; Rizzi, M.; Manzi, R.

In: Tumori, Vol. 81, No. 3, 1995, p. 197-200.

Research output: Contribution to journalArticle

Villani, F, Galimberti, M, Mazzola, G, Stifani, I, Santinami, M, Rizzi, M & Manzi, R 1995, 'Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion', Tumori, vol. 81, no. 3, pp. 197-200.
Villani F, Galimberti M, Mazzola G, Stifani I, Santinami M, Rizzi M et al. Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion. Tumori. 1995;81(3):197-200.
Villani, F. ; Galimberti, M. ; Mazzola, G. ; Stifani, I. ; Santinami, M. ; Rizzi, M. ; Manzi, R. / Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion. In: Tumori. 1995 ; Vol. 81, No. 3. pp. 197-200.
@article{727af0de736440b88ccc498866e5ff01,
title = "Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion",
abstract = "Aims: We studied cardiac and pulmunary function in 22 patients affected by in transit metastases from cutaneous melanoma and metastases from soft tissue sarcoma of the limbs and treated with isolation perfusion in extracorporeal circulation with rTNF alpha at doses ranging from 0.5 to 4 mg/m2 in mild hyperthermia. Patients and methods: All patients experienced a septic-like shock syndrome of variable severity: this feature lasted from 24 to 72 h and was controlled by the infusion of dopamine. Seventeen patients suffered from respiratory insufficiency, which required assisted ventilation (7 cases mechanical ventilation for 1 day, 8 cases for 2 days, and 2 cases synchronized intermittent mandatory ventilation). Results: Spirometric parameters recorded 7-15 days after treatment did not change from baseline values. In contrast, lung transfer factor for carbon monoxide significantly declined in a dose dependent fashion. Conclusions: Our data confirm that rTNF alpha administered by isolation perfusion technique induces systemic cardiovascular and pulmonary side effects. Further studies are required to better define time course and reversibility of impaired pulmonary function.",
keywords = "cardiotoxicity, pneumotoxicity, tumor necrosis factor",
author = "F. Villani and M. Galimberti and G. Mazzola and I. Stifani and M. Santinami and M. Rizzi and R. Manzi",
year = "1995",
language = "English",
volume = "81",
pages = "197--200",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Cardiac and pulmonary effects of alpha tumor necrosis factor administered by isolation perfusion

AU - Villani, F.

AU - Galimberti, M.

AU - Mazzola, G.

AU - Stifani, I.

AU - Santinami, M.

AU - Rizzi, M.

AU - Manzi, R.

PY - 1995

Y1 - 1995

N2 - Aims: We studied cardiac and pulmunary function in 22 patients affected by in transit metastases from cutaneous melanoma and metastases from soft tissue sarcoma of the limbs and treated with isolation perfusion in extracorporeal circulation with rTNF alpha at doses ranging from 0.5 to 4 mg/m2 in mild hyperthermia. Patients and methods: All patients experienced a septic-like shock syndrome of variable severity: this feature lasted from 24 to 72 h and was controlled by the infusion of dopamine. Seventeen patients suffered from respiratory insufficiency, which required assisted ventilation (7 cases mechanical ventilation for 1 day, 8 cases for 2 days, and 2 cases synchronized intermittent mandatory ventilation). Results: Spirometric parameters recorded 7-15 days after treatment did not change from baseline values. In contrast, lung transfer factor for carbon monoxide significantly declined in a dose dependent fashion. Conclusions: Our data confirm that rTNF alpha administered by isolation perfusion technique induces systemic cardiovascular and pulmonary side effects. Further studies are required to better define time course and reversibility of impaired pulmonary function.

AB - Aims: We studied cardiac and pulmunary function in 22 patients affected by in transit metastases from cutaneous melanoma and metastases from soft tissue sarcoma of the limbs and treated with isolation perfusion in extracorporeal circulation with rTNF alpha at doses ranging from 0.5 to 4 mg/m2 in mild hyperthermia. Patients and methods: All patients experienced a septic-like shock syndrome of variable severity: this feature lasted from 24 to 72 h and was controlled by the infusion of dopamine. Seventeen patients suffered from respiratory insufficiency, which required assisted ventilation (7 cases mechanical ventilation for 1 day, 8 cases for 2 days, and 2 cases synchronized intermittent mandatory ventilation). Results: Spirometric parameters recorded 7-15 days after treatment did not change from baseline values. In contrast, lung transfer factor for carbon monoxide significantly declined in a dose dependent fashion. Conclusions: Our data confirm that rTNF alpha administered by isolation perfusion technique induces systemic cardiovascular and pulmonary side effects. Further studies are required to better define time course and reversibility of impaired pulmonary function.

KW - cardiotoxicity

KW - pneumotoxicity

KW - tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0029129473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029129473&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 197

EP - 200

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -